PRECLINICAL DEVELOPMENT OF MOXIDECTIN AS A NOVEL THERAPEUTIC FOR ALCOHOL USE DISORDER

Current pharmacotherapies for alcohol used disorder (AUD) are few and relatively ineffective illustrating the need for the development of new, effective medications. Using a translational approach, our laboratory reported that ivermectin, an FDA-approved, human and animal anti-parasitic agent, can s...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuropharmacology
Autori principali: Huynh, Nhat, Arabian, Natalie, Naito, Anna, Louie, Stan, Jakowec, Michael W., Asatryan, Liana, Davies, Daryl L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5148646/
https://ncbi.nlm.nih.gov/pubmed/27641072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2016.09.016
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi